LABZF vs CRM: Which Stock is Better?
Side-by-side comparison of LABZF and Salesforce Inc in 2026
LABZF
LABZF
$0.11
CRM
Salesforce Inc
$182.14
Key Metrics Comparison
| Metric | LABZF | CRM | Winner |
|---|---|---|---|
| Market Cap | $2.03M | $169.80B | CRM |
| P/E Ratio | N/A | 23.26 | CRM |
| EPS (TTM) | $N/A | $7.79 | CRM |
| Revenue Growth | -1.0% | 0.1% | CRM |
| Gross Margin | 8.0% | 77.7% | CRM |
Analyze LABZF
Full quant analysis
Analyze CRM
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is LABZF or CRM a better investment?
Comparing LABZF and CRM: LABZF has a market cap of $2.03M while Salesforce Inc has $169.80B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between LABZF and CRM?
LABZF (LABZF) and CRM (Salesforce Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: LABZF or CRM?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: LABZF or CRM?
CRM has higher revenue growth at 0.1% vs -1.0% for LABZF.
Which company is more profitable: LABZF or CRM?
Salesforce Inc (CRM) has higher gross margins at 77.7% compared to 8.0% for LABZF.
Which is the larger company: LABZF or CRM?
Salesforce Inc (CRM) is larger with a market cap of $169.80B compared to $2.03M for LABZF.
Should I buy LABZF or CRM in 2026?
Both LABZF and CRM have investment merit. LABZF trades at $0.11 while CRM trades at $182.14. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between LABZF and CRM stock?
Key differences: Market Cap ($2.03M vs $169.80B), P/E Ratio (N/A vs 23.3x), Revenue Growth (-1.0% vs 0.1%), Gross Margin (8.0% vs 77.7%).